Hepatitis C virus: Historical perspective and current concept

FEMS Microbiology Reviews

Volumn 14, Issue 3, 1994, Pages 181-191

  Purcell, Robert H ^a  

^a National Institute for Allergy and Infectious Disease   (United States)

Author keywords

Flavivirus; Hepatitis C; Non A non B hepatitis; Transmission studies

Indexed keywords

CONFERENCE PAPER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NONHUMAN;

ANIMAL; HEPACIVIRUS; HEPATITIS C; HUMAN;

FLAVIVIRIDAE; FLAVIVIRUS; HEPATITIS C VIRUS; NON-A, NON-B HEPATITIS VIRUS;

EID: 0028358227     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.1994.tb00087.x     Document Type: Article

References (104)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome
2. Viral hepatitis: multiple attacks in a narcotic addict
3. Homologous serum hepatitis in youthful heroin users
4. Multiple Attacks of Hepatitis in Drug Addicts: Biochemical, Immunochemical, and Morphologic Characteristics
5. An outbreak of hepatitis associated with intravenous injection of factor VIII concentrate
6. Serum hepatitis from transfusions of blood
7. lnfectious hepatitis. Evidence for two distinctive clinical, epidermiological and imnmnological types of infection
8. Viral hepatitis: and serologic procedures in the study of an epidemic
9. Serum glutamic oxalacetic transminase activity as an index of liver cell injury a prelimenary report
10. The diagnostic, prognostic and epidemiologic significance of alterations in serum glutamic pyruvic (SGP-T) transaminase in hepatitis
11. The incidence of viral hepatitis after blood transfusion
12. Post transfusion anticteric hepatitis
13. Incidence and course of icteric and anicteric transfusion hepatitis
14. Posttransfusion hapatitis after open-hear operations: incidence after the administration of blood from commercial and volunteer donor populations
15. Risk of posttransfusion hepatitis in the United States: a prospective cooperative study
16. Posttransfusion hepatitis etiology and prevention
17. The consequences ot administering blood pretested for HBsAg by third generation techniques: a progress report
18. Transfusion-transmitted viruses: interim analysis of hepatitis among transfused and nontransfused patients
19. Posttransfusion hepatitis, 1973–1975: a Veterans Administration cooperative study
20. A new antigen in leukemia serum
21. Correlation of Australia antigen with posttransfusion hepatitis
22. A prospective study of posttransfusion hepatitis: the role of the Australia antigen
23. The infectivity of blood containing the Australian antigen
24. Hepatitis A detection by immune electron microscopy of a virus-like antigen associated with acute illness
25. Transfusion-associated hepatitis not due to viral hepatitis type A or B
26. Transmissible agent in non-A, non-B hepatitis
27. Transmission of non-A, non-B hepatitis from man to chimpanzee
28. Non-A, non-B hepatitis: identification of a virus-specific antigen and antibody: a preliminary report
29. Non-A, non-B hepatitis transmission in chimpanzees: a project of the Transfusion-Transmitted Viruses Study Group
30. Transmission of non-A, non-B hepatitis
31. Non-A, Non-B Hepatitis after Experimental Transmission of Malaria by Inoculation of Blood
32. Early events in hepatitis C virus infection of chimpanzees.
33. Experimental infection of chimpanzees with anti-hemophilic (factor VIII) materials: Recovery of virus-like particles associated with non-A, non-B hepatitis
34. Transmission of non-A, non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patient with chronic liver disease
35. New human hepatitis virus (lett)
36. Viruslike particles in a plasma fraction (fibrinogen) and in the circulation of apparently healthy blood donors capable of inducing non-A/non-B hepatitis in humans and chimpanzees
37. Transmission of non-A, non-B hepatitis to chimpanzees (abstr)
38. Evaluation of a chimpanzee colony for anti-bodies to hepatitis C virus
39. Absence of nonpercutaneous transmission of hepatitis C virus in a colony of chimpanzee
40. Non-A, non-B hepatitis in chimpanzees and marmosets
41. Primate animal models and titered inocula for the study of human hepatitis A, hepatitis B and non non-A, non-B hepatitis
42. Non-A, non-B hepatitis: toward the discovery of hepatitis C and E viruses
43. Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform
44. Posttransfusion non-A, non-B hepatitis: Physicochemical properties of two distinct agents
45. Non-A non-B hepatitis virus: Determination of size by filtration
46. Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose
47. Non-A, non-B (type 1) hepatitis agent capable of inducing tabular ultrastructures in the hepatocyte cytoplasm of chimpanzees: inactivation of formalin
48. The chimpanzee animal model for non-A, non-B hepatitis: new applications
49. Hepatitis B virus, hepatitis non-A, non-B virus and hepatitis delta virus in lyophilized antihemophilic factor: relative sensitivity to heat
50. Sterilization of hepatitis and HTLV-III viruses by exposure to tri (n-butyl) phosphate and sodium cholate
51. Inactivation of an agent of human non-A, non-B hepatitis by formalin
52. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propriolactone and ultra-violet irradiation
53. Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus
54. Acquired immunity to human non-A, non-B hepatitis: cross-challenge of chimpanzees with three infectious human sera
55. Non-A/non-B hepatitis in experimentally infected chimpanzees: cross-challenge and electron microscopic studies
56. Transfusion-transmitted viruses study: experimental evidence for two non-A, non-B hepatitis agents
57. Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees
58. Additional evidence for more than one agent of human non-A, non-B hepatitis: transmission and passage studies in chimpanzees
59. Long-term sequelae of non-A, non-B hepatitis in experimentally infected chimpanzees
60. Non-A, non-B hepatitis virus: is there more than a single blood-borne strain?
61. Transmission of non-A, non-B hepatitis to chimpanzees: a second and third episode caused by the same inoculum
62. Lack of protective immunity against reinfection with hepatitis C virus
63. Immunity in hepatitis C infection
64. Parentally transmitted non-A, non-B hepatitis: virus-specific antibody response patterns in hepatitis C virus-infected chimpanzees
65. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis
66. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia
67. Three different patterns of hepatitis C virus infection in chimpanzees
68. Temporal relationships of hepatitis C virus RNA and antibody responses following experiment infection of chimpanzees
69. Follow-up of hepatitis C virus infection in chimpanzees: determination of viraemia and specific humoral immune response
70. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology
71. Experimental infection of tamarins with human non-A, non-B hapatatis virus
72. Studies on transmission of human non-a, non-B hepatitis to marmosets
73. Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by a vitro transformation with Epstein-Barr virus
74. Non-A, non-B specific antibodies directed at host-derived epitope: implication for an autoimmune process
75. Rheumatoid factor-like reactants in sera proven to transmit non-A, non-B hepatitis: a potential source of false positive reactions in non-A, non-B assays
76. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.
77. Evidence for immune selection of hepatitis V virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections
78. Genetic drift of hepatitis C virus during and 8.2-year infection in a chimpanzee: variability and stability
79. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes
80. Monoclonal radioimmunoassays for hepatitis B surface antigen: demostration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes
81. Detection and transmission in chimpanzees of hepatitis B agents formerly designated ‘non-A, non-B’ hepatitis
82. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases.
83. Detection of reverse transcriptase activity in association with non-A, non-B hepatitis agent(s)
84. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
85. Isolation of a cDNA from the virus rsponsible for enterically transmitted non-A, non-B hepatitis
86. Family Flaviviridae
87. Molecular biology of the hepatitis C viruses implications for diagnosis, development and control of viral disease
88. Hepatitis C virus RNA in southern African Blacks with hepatocellular carcinoma
89. Sequence analysis of the 5′ noncoding region of hepatitis C virus
90. At least five related, but distinct, hepatitis C viral genotypes exist
91. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants
92. Identification hepatitis C viruses with a nonconserved sequence of the 5′ untranslated region
93. Typing hepatitis C virus by polynmerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources
94. Detection of three types of hepatitis C virus in blood donors: investigation fo type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities
95. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restriction on sequence diversity
96. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected worldwide
97. Severity of liver disease with different hepatitis C viral clones
98. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus
99. The degree of variability in the amino terminal region of the E2/NSI protein of hepatitis C virus correlates with resposiveness to interferon therapy in viremic patients
100. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus antibody
101. Non-A, non-B hepatitis. I. Rccognition, epidermiology, and clinical features
102. Non-A, non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention
103. Transfusion-associated hepatitis
104. Natural history deduced from experimental infections in primates